Incidence of fractures in patients with multiple sclerosis: The Danish National Health Registers

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 622-627

  Bazelier, Marloes T ^a   De Vries, Frank ^a,b,c   Bentzen, Joan ^d   Vestergaard, Peter ^e   Leufkens, Hubert G M ^a   Van Staa, Tjeerd Pieter ^a,b,f   Koch Henriksen, Nils ^g,h  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^g Rigshospitalet   (Denmark)

^h AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

epidemiology; fracture; multiple sclerosis; osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; BIRTH; CONTROLLED STUDY; DENMARK; DISEASE REGISTRY; FEMALE; FEMUR FRACTURE; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE SCLEROSIS; TIBIA FRACTURE;

EID: 84860491050     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511426739     Document Type: Article

References (25)

1. Ragonese P, Aridon P, Salemi G, D'Amelio M, Savettieri G. Mortality in multiple sclerosis: a review. Eur J Neurol. 2008 ; 15: 123-127
2. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000 ; 343: 1430-1438
3. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999 ; 353: 878-882
4. Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, et al. Risk of bone loss in men with multiple sclerosis. Mult Scler. 2004 ; 10: 170-175
5. Hearn AP, Silber E. Osteoporosis in multiple sclerosis. Mult Scler. 2010 ; 16: 1031-1043
6. Formica CA, Cosman F, Nieves J, Herbert J, Lindsay R. Reduced bone mass and fat-free mass in women with multiple sclerosis: effects of ambulatory status and glucocorticoid use. Calcif Tissue Int. 1997 ; 61: 129-133
7. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005 ; 23: 309-313
8. Cosman F, Nieves J, Komar L, Ferrer G, Herbert J, Formica C, et al. Fracture history and bone loss in patients with MS. Neurology. 1998 ; 51: 1161-1165
9. Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milano E, et al. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab. 2004 ; 89: 4923-4928
10. Schett G, David JP. The multiple faces of autoimmune-mediated bone loss. Nat Rev Endocrinol. 2010 ; 6: 698-706
11. Nilsagård Y, Lundholm C, Denison E, Gunnarsson LG. Predicting accidental falls in people with multiple sclerosis-a longitudinal study. Clin Rehabil. 2009 ; 23: 259-269
12. Peterson EW, Cho CC, von Koch L, Finlayson ML. Injurious falls among middle aged and older adults with multiple sclerosis. Arch Phys Med Rehabil. 2008 ; 89: 1031-1037
13. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999 ; 46: 263-268
14. Mosbech J, Jørgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD. The national patient registry. Evaluation of data quality. Ugeskr Laeger. 1995 ; 157: 3741-3745
15. Allison RS, Millar JHD. Prevalence and familial incidence of disseminated sclerosis. Ulster Med J. 1954 ; 23: 5-27
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
18. Koch-Henriksen N, Rasmussen S, Stenager E, Madsen M. The Danish Multiple Sclerosis Registry. History, data collection and validity. Dan Med Bull. 2001 ; 48: 91-94
19. Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P, et al. The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res. 2011 ;:
20. Cheng SY, Levy AR, Lefaivre KA, Guy P, Kuramoto L, Sobolev B. Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int. 2011 ;:
21. Stenager E, Jensen K. Fractures in multiple sclerosis. Acta Neurol Belg. 1991 ; 91: 296-302
22. Logan WC, Sloane R, Lyles KW, Goldstein B, Hoenig HM. Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury. Arch Phys Med Rehabil. 2008 ; 89: 237-243
23. Troiano RA, Jotkowitz A, Cook SD, Bansil S, Zito G. Rate and types of fractures in corticosteroid-treated multiple sclerosis patients. Neurology. 1992 ; 42: 1389-1391
24. Vestergaard P, Krogh K, Rejnmark L, Mosekilde L. Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord. 1998 ; 36: 790-796
25. Vestergaard P, Glerup H, Steffensen BF, Rejnmark L, Rahbek J, Moseklide L. Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabil Med. 2001 ; 33 (4). 150-155